‌

US Patent 8329871 Process of purifying coagulation factor VIII

Patent 8329871 was granted and assigned to Octapharma on December, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Octapharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8329871

Patent Inventor Names

Stefan Winge0

Ulrika Ericsson0

Carin Borgvall0

Gustav Gilljam0

Mats Jernberg0

Date of Patent

December 11, 2012

Patent Application Number

12737230

Date Filed

June 24, 2009

Patent Citations Received

‌

US Patent 12071468 Purification of Factor VIII subspecies

Patent Primary Examiner

‌

Kagnew H Gebereyesus

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8329871 Process of purifying coagulation factor VIII

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API